Abstract
The killer cell inhibitory receptors (KIR) are a family of immunoglobulin (Ig)-like cell surface receptors which are differentially expressed by cytotoxic lymphocyte populations and recognize subsets of human leukocyte antigen (HLA) class I molecules on potential target cells (Long et al. 1996). Originally identified as inhibitory receptors of natural killer (NK) cells having discrete specificities for HLA class I allotypes, KIR are also expressed by a small but significant population of T cells (Ferrini et al. 1994; Mingari et al. 1995; Phillips et al. 1995). Importantly, KIR recognition of their complementary class I ligands can modulate T cell function in a manner comparable to that observed for NK cells. This contribution summarizes recent advances in understanding the functional significance of T cell expression of KIR family members.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamkiewicz TV, McSherry C, Bach FH, Houchins JP (1994) Natural killer lectin-like receptors have divergent carboxy-termini, distinct from C-type lectins. Immunogenetics 39: 218
Albi N, Ruggeri L, Aversa F, Merigiola C, Tosti A, Tognellini R, Grossi CE, Martelli MF, Velardi A (1996) Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after “three-loci” HLA-incompatible bone marrow transplantation. Blood 87: 3993–4000
Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L (1996) The human leukocyte antigen ( HLA)-C-specific “activitory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 183: 645–650
Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet J-P, Abraham RT, Leibson PJ (1996) Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5: 629–638
Brennan J, Mager D, Jefferies W, Takei F (1994) Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med 180: 2287–2295
Brennan J, Mahon G, Mager DL, Jefferies WA, Takei F (1996) Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions. J Exp Med 183: 1553–1559
Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P, Long EO (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4: 77–85
Campbell KS, Dessing M, Lopez-Botet M, Cella M, Colonna M (1996) Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 184: 93–100
Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL (1995) Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 25: 2433–2437
Colonna M, Samaridis J (1995) Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human NK cells. Science 268: 405–408
Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL (1993) HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 90: 12000–12004
Correa I, Raulet DH (1995) Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2: 61–71
D’Ambrosio D, Hippen KL, Minskoff SA, Mellman I, Pani G, Siminovitch KA, Cambier JC (1995) Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcyRIIBI. Science 268: 293–297
D’Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL (1995) Molecular cloning of NKB 1: A natural killer cell receptor for HLA-B allotypes. J Immunol 155: 2306–2310
D’Andrea A, Chang C, Phillips JH, Lanier LL (1996) Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J Exp Med 184: 789–794
Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH (1995) The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcyRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3: 635–646
Daniels B, Karlhofer FM, Seaman WE, Yokoyama WM (1994) A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med 180: 687–692
Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M (1996) A human killer inhibitory receptor specific for HLA-A. J Immunol 156: 3098–3101
Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L (1994) T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol 24: 2294–2298
Fry A, Lanier LL, Weiss A (1996) Phosphotyrosines in the KIR motif of NKB 1 are required for negative signaling and for association with PTP1C. J Exp Med 184: 295–300
Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134–141
Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IC (1996) A ab T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274: 209–221
Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB 1, a putative HLA receptor. J Exp Med 181: 1133–1144
Gumperz JE, Valiante NM, Parham P, Lanier LL, Tyan D (1996) Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different HLA types appear genetically regulated, but not linked to MHC haplotype. J Exp Med 183: 1817–1827
Guthmann MD, Tal M, Pecht I (1995) A secretion inhibitory signal transduction molecule on mast cells is another C-type lectin. Proc Natl Acad Sci USA 92: 9397–9401
Houchins JP, Yabe T, McSherry C, Bach FH (1991) DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 173: 1017–1020
Houchins JP, Lanier LL, Niemi E, Phillips JH, Ryan JC (1997) Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 158: 3603–3609
Karlhofer FM, Ribuado RK, Yokoyama WM (1992) MHC class I alloantigen specificity of Ly-49+ IL-2activated natural killer cells. Nature 358: 66–70
Kane K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319: 675–678
Katz HR, Vivier E, Castells MC, McCormick MJ, Chambers JM, Austen KF (1996) Mouse mast cell gp49B 1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc Natl Acad Sci USA 93: 10809–10814
Lanier LL (1997) NK cell receptors and MHC class I interactions. Curr Opin Immunol 9:126–131 Lanier LL, Corliss B, Phillips JH (1997) Arousal and inhibition of human NK cells. Immunol Rev 155: 145–154
Law C-L, Sidorenko SP, Chandran KA, Zhao Z, Shen S-H, Fischer EH, Clark EA (1996) CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase Cgl upon B cell activation. J Exp Med 184: 547–560
Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH (1996) Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157: 4741–4745
Lenschow DJ, Walunas TL, Bluestone JA (1996) CD28B7 system of T cell costimulation. Annu Rev Immunol 14: 233–258
Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL (1994) NKB1: an NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 180: 537–543
Ljunggren H-G, Karre K (1990) In search of the `missing self’: MHC molecules and NK cell recognition. Immunol Today 11: 237–244
Long EO, Colonna M, Lanier LL (1996) Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol Today 17: 100
Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO (1995) Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267: 1016–1018
Mandelboim O, Davis DM, Reyburn HT, Vales-Gomez M, Sheu EG, Pazmany L, Strominger JL (1996) Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science 274: 2097–2100
Mason LH, Ortaldo JR, Young HA, Kumar K, Bennett M, Anderson SK (1995) Cloning and functional characteristics of murine LGL-1: a member of the Ly-49 gene family (Ly-49G2). J Exp Med 182: 293–304
Mingari MC, Vitale C, Cambiaggi A, Schiavetti F, Melioli G, Ferrini S, Poggi A (1995) Cytotoxic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis of lymphokine production. Int Immunol 7: 697–703
Mingari MC, Schiavetti F, Ponte M, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS, Moretta L (1996) Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA 93: 12433–12438
Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, Barbaresi M, Ciccone E, Moretta L (1993) p58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 178: 597–604
Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch RV (1994) A 13-amino acid motif in the cytoplasmic domain of FcgRIIB modulates B-cell receptor signalling. Nature 368: 70–73
Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier IC, Vivier E (1996) Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 156: 4531–4534
Orihuela M, Margulies DH, Yokoyama WM (1996) The NK cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its MHC class I ligand. Proc Natl Acad Sci USA 93: 11792–11797
Pani G, Kozlowski M, Cambier IC, Mills GB, Siminovitch KA (1995) Identification of the tyrosine phosphatase PTP 1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J Exp Med 181: 2077–2084
Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, Di Donato C, Accame O, Bottino C, Moretta A, Moretta L (1996) The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 184: 505–518
Peruzzi M, Parker KC, Long EO, Malnati MS (1996) Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 157: 3350–3356
Phillips JH, Gumperz JE, Parham P, Lanier LL (1995) Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268: 403–405
Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL (1996) CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, -B, and -C allotypes. Immunity 5: 163–172
Sarkar S, Schlottmann K, Cooney D, Coggeshall KM (1996) Negative signaling via FcgammaRIIB 1 in B cells blocks phospholipase Cgamma2 tyrosine phosphorylation but not Syk or Lyn activation. J Biol Chem 271: 20182–20186
Scott P, Trinchieri G (1995) The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 7: 34–40
Sivori S, Vitale M, Bottino C, Marcenaro E, Parolini S, Moretta L, Moretta A (1996) CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 26: 2487–2492
Spits H, Lanier LL, Phillips JH (1995) Development of human T and natural killer cells. Blood 85: 2654–2670
Stoneman ER, Bennett M, An J, Chesnut KA, Scheerer JB, Siciliano MJ, Kumar V, Mathew PA (1995) Cloning and characterization of 5E6 (Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med 182: 305–314
Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO (1995) Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra-and intracellular domains. Immunity 2: 439–449
Yabe T, McSherry C, Bach FH, Fisch P, Schall RP, Sondel PM, Houchins JP (1993) A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 37: 455–460
Yokoyama WM (1995) Natural killer cell receptors. Curr Opin Immunol 7: 110–120
York IA, Rock KL (1996) Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 14: 369–396
Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pirchet H, Hengartner H (1996) On immunological memory. Annu Rev Immunol 14: 333–367
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
D’Andrea, A., Lanier, L.L. (1998). Killer Cell Inhibitory Receptor Expression by T Cells. In: Kärre, K., Colonna, M. (eds) Specificity, Function, and Development of NK Cells. Current Topics in Microbiology and Immunology, vol 230. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46859-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-46859-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46861-2
Online ISBN: 978-3-642-46859-9
eBook Packages: Springer Book Archive